PreveCeutical Medical Inc.
PRVCF
Rank in Stocks
#29054
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Share Price
$0.0123
Last synced: 2026-11-09
Market Cap
$9.04M
Change (1 day)
-20.65%
Change (1 year)
-22.54%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PreveCeutical Medical Inc. (PRVCF)
Category
Healthcare
Operating Margin for PreveCeutical Medical Inc. (PRVCF)
Operating Margin as of November 2026 TTM: 0.00%
According to PreveCeutical Medical Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for PreveCeutical Medical Inc. from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | -115,715.57% | 256,077.93% |
| 2018 | -45.17% | -99.78% |
| 2017 | -20,209.31% | 132.03% |
| 2016 | -8,709.63% | 0.00% |
| 2015 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PreveCeutical Medical Inc.'s operating margin
What was PreveCeutical Medical Inc.'s operating margin in 2025?
In 2025, PreveCeutical Medical Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has PreveCeutical Medical Inc.'s operating margin changed since 2020?
From 2020 to 2025, PreveCeutical Medical Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does PreveCeutical Medical Inc.'s operating margin compare with similar companies?
PreveCeutical Medical Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.